Feature Channels:

Pharmaceuticals

Add to Favorites Subscribe Share
fbshare-Pharmaceuticals

Showing results

110 of 3289
SBA_logo.png

Article ID: 714389

New Natural Therapeutic Agent to Fight Diabetic Nephropathy

Sbarro Health Research Organization (SHRO)

The extract successfully restored the blood glucose levels, body weight, and normalized oxidative stress on renal function in a test group of Zucker diabetic fatty rats.

Released:
14-Jun-2019 11:05 AM EDT
Newswise: Researchers develop drug-targeting molecules to improve cancer treatment

Article ID: 714299

Researchers develop drug-targeting molecules to improve cancer treatment

University of Notre Dame

Researchers from the University of Notre Dame have developed small drug-targeting molecules that may be hundreds to thousands of times more effective at delivering potent drugs to desired sites of disease, including cancer.

Released:
12-Jun-2019 1:05 PM EDT
Newswise: A Homing Beacon for Chemotherapy Drugs
  • Embargo expired:
    12-Jun-2019 8:00 AM EDT

Article ID: 714093

A Homing Beacon for Chemotherapy Drugs

American Chemical Society (ACS)

Researchers have made a hydrogel that, when injected near tumors in mice, recruits drugs to shrink the tumor with fewer side effects. They report their results in ACS Central Science.

Released:
7-Jun-2019 10:00 AM EDT
WoltersKluwer_CMYK-ol.jpg

Article ID: 714253

Nurses Urged to Practice 'Evidence-Based Compassion' for Alcohol Use Disorder

Wolters Kluwer Health: Lippincott Williams and Wilkins

Nurses play a critical role in promoting compassionate care for patients and families affected by alcohol use disorder (AUD), including evidence-based medication-assisted treatment (MAT) approaches, according to a paper in the July/September Journal of Christian Nursing, official journal of the Nurses Christian Fellowship. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released:
11-Jun-2019 3:05 PM EDT
Newswise: Quatre millions de dollars pour le criblage de médicaments

Article ID: 714234

Quatre millions de dollars pour le criblage de médicaments

The Neuro - Montreal Neurological Institute and Hospital

L’Institut et hôpital neurologiques de Montréal (le Neuro) dirigera un partenariat en science ouverte en vue de la mise au point de médicaments de précision indiqués dans la sclérose latérale amyotrophique (SLA) et la maladie de Parkinson (MP).

Released:
11-Jun-2019 1:05 PM EDT
Newswise: $4M for open science drug screening

Article ID: 714233

$4M for open science drug screening

The Neuro - Montreal Neurological Institute and Hospital

The Neuro (Montreal Neurological Institute and Hospital) will lead an open science partnership to develop precision drugs for amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD).

Released:
11-Jun-2019 12:05 PM EDT
ScreenShot2016-07-21at10.42.00AM.png

Article ID: 714224

Drug to Treat Malaria Could Mitigate Hereditary Hearing Loss

Case Western Reserve University

The ability to hear depends on proteins to reach the outer membrane of sensory cells in the inner ear. But in certain types of hereditary hearing loss, mutations in the protein prevent it from reaching these membranes.

Released:
11-Jun-2019 11:50 AM EDT
Newswise: Neutrons allow analysis of polymer gels’ unusual attributes

Article ID: 714026

Neutrons allow analysis of polymer gels’ unusual attributes

Oak Ridge National Laboratory

Researchers used neutron scattering at ORNL’s Spallation Neutron Source to investigate the response properties of polymer gels commonly used in products like cosmetics, adhesives, and paints. A better understanding of their behaviors will lead to improved products and potential new medical applications for drug delivery.

Released:
6-Jun-2019 11:05 AM EDT
Newswise: UCLA researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer
  • Embargo expired:
    6-Jun-2019 11:00 AM EDT

Article ID: 713970

UCLA researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer

University of California, Los Angeles (UCLA), Health Sciences

A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.

Released:
5-Jun-2019 12:15 PM EDT

Showing results

110 of 3289

Chat now!